GleamWall
中文EN

XGN EXAGEN INC.

Services-Medical Laboratories · Nasdaq · SEC CIK 1274737 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY13.7%
TTM net income YoY4.6%
TTM EPS YoY18.3%
Revenue 3-yr CAGR11.9%
Net income 3-yr CAGR—

Margins

Gross margin58.7%
Operating margin-20.1%
Net margin-25.1%
FCF margin-18.0%
EBITDA margin-16.6%

Returns

ROE-113.9%
ROA-30.8%
ROIC (approx.)-167.2%
Asset turnover1.22x

Leverage & solvency

Liabilities / assets75.1%
Debt / equity1.66x
Current ratio3.46x
Interest coverage-2.90x

Cash quality & payout

Operating cash flow / net income0.66x
Accruals ratio-10.4%
Payout ratio—
Capex / revenue1.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$66.58M$55.64M
Cost of revenue$27.78M$22.53M
Gross profit$38.80M$33.11M
R&D expense$6.25M$5.38M
SG&A expense$46.62M$41.37M
Operating income-$14.07M-$13.64M
Interest expense$4.32M$2.23M
Income tax$51,000$12,000
Net income-$19.95M-$15.12M
EBITDA-$11.97M-$11.94M
EPS (basic)-0.93-0.83
EPS (diluted)-0.93-0.83
Weighted avg. shares (diluted)21.56M18.20M
Balance sheet
Cash & equivalents$32.22M$22.24M
Receivables$10.86M$7.83M
Current assets$48.89M$36.45M
PP&E, net$6.94M$5.28M
Total assets$58.02M$44.69M
Current liabilities$14.16M$13.51M
Short-term debt$643,000$423,000
Long-term debt$22.26M$19.82M
Total debt$22.91M$20.25M
Total liabilities$40.57M$35.15M
Shareholders' equity$17.45M$9.54M
Net debt-$9.31M-$1.99M
Shares outstanding22.91M17.64M
Cash flow statement
Operating cash flow-$13.62M-$13.28M
Capital expenditure$641,000$515,000
Free cash flow-$14.27M-$13.79M
Investing cash flow-$626,000-$515,000
Financing cash flow$24.43M-$663,000
Depreciation & amortization$2.10M$1.70M
Stock-based compensation$2.16M$1.76M

Free plan shows the latest 2 periods; Pro shows all 8 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.